Search
for
Sort by
Research 31–60 of 62
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Advances in Research of Hydrogel Microneedle-Based Delivery Systems for Disease Treatment
- Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
- Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Cancer-Related Alopecia: From Etiologies to Global Management
- XMU-MP-1 induces growth arrest in a model human mini-organ and antagonises cell cycle-dependent paclitaxel cytotoxicity
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Mild oxidative stress protects against chemotherapy-induced hair loss
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Melatonin protects K15+ human hair follicle stem cells and hair matrix keratinocytes against paclitaxel-induced damage ex vivo
- Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
- The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis
- Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications
- Cold Atmospheric Plasma for Breast Cancer
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Beyond the Follicle: A Narrative Review on How Systemic Diseases and Drugs Affect Alopecia
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Cancer-Related Alopecia Risk and Treatment
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Breast cancer in a transgender man